Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen: A Multi-Center Analysis
Follicular Lymphoma (FL) is a common form of non-Hodgkin lymphoma with a wide spectrum of presentation. While Grade 1-2 FL is considered low-grade and Grade 3B FL is approached as an aggressive lymphoma, the management of Grade 3A FL remains a controversy. We performed a retrospective, multicenter analysis of patients aged ≥ 18 years with advanced stage 3-4 Grade 3A FL diagnosed between January 2006-July 2016. Patients were stratified by frontline chemotherapy regimen: anthracycline based (ATC), bendamustine (BD), and cyclophosphamide-vincristine-prednisone (CVP).
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Nirav N. Shah, Aniko Szabo, Raya Saba, Lauren Strelec, Dheeraj Kodali, John L. Vaughn, Olukemi Esan, David T. Yang, Anthony R. Mato, Abraham S. Kanate, Horatiu Olteanu, Mehdi Hamadani, Timothy S. Fenske, Vaishalee P. Kenkre, Jakub Svoboda, Amanda F. Cashe Source Type: research
More News: Chemotherapy | Leukemia | Lymphoma | Myeloma | Non-Hodgkin's Lymphoma | Prednisone | Treanda